Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2288 of 6351
-
AI chatbot may boost colonoscopy prep and ease nerves — trial puts it to the test
Symptom relief CompletedBackground and rationale: Colonoscopy is central to colorectal cancer screening and prevention, but its diagnostic yield depends heavily on adequate bowel preparation; inadequate cleansing lowers adenoma detection and often necessitates repeat procedures. Pre-procedural anxiety i…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Turmeric power: could curcumin nanogels replace steroids for a painful mouth condition?
Disease control Recruiting nowThis randomized, double-blind clinical trial evaluates the therapeutic effects of curcumin in nanogels compared to 0.1% fluocinolone acetonide oral paste in the management of atrophic-erosive oral lichen planus (OLP). The study aims to determine whether curcumin nanogels, a natur…
Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New checklist aims to curb deadly bleeding in african C-Sections
Disease control Recruiting nowThe quality improvement project evaluating the delivery of a perioperative care complex intervention to improve haemorrhage-related outcomes in patients undergoing caesarean section. The objectives of the current study will be: 1. To evaluate whether implementation of the 'Rule …
Sponsor: Bruce Biccard • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New study tracks rare brain disease in china to unlock its secrets
Knowledge-focused Recruiting nowMultiple system atrophy is a rare, rapidly progressive neurodegenerative disease characterized by variable combinations of parkinsonism, cerebellar ataxia, and autonomic dysfunction. Existing natural history studies from North America, Europe, and Japan suggest that clinical phen…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Biomarkers may reveal who recovers from Work-Related asthma
Knowledge-focused CancelledOccupational exposure is known to cause 15% of asthma cases. The main treatment for occupational asthma is to stop exposure if possible. Although, remission of occupational asthma only occurs in only 30 % of patients after cessation of exposure. There is currently no way of predi…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
PET scans probe whether brain inflammation fuels 'chemo brain' in breast cancer
Knowledge-focused CancelledThis clinical study will use the small molecule translocator protein (TSPO) ligand, 18F-labeled DPA-714, to visualize and quantify neuroinflammation in treatment naive women with stage II-III newly diagnosed breast cancer (without brain metastases) prior to starting neoadjuvant c…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Virtual reality offers new hope for chronic back pain sufferers
Symptom relief OngoingParticipants with chronic back pain will complete an online Qualtrics eligibility survey. After signing a consent form, eligible participants enter a two-week baseline period ("Baseline Period"), during which they complete two assessments of the Primary and Secondary Outcome Meas…
Sponsor: CognifiSense Inc. • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Gentler heart bypass: new No-Touch aorta technique tested in 260-Patient trial
Disease control Recruiting nowThe goal of this single-center prospective cohort study is to compare perioperative safety metrics and follow-up survival analyses in patients receiving Minimally Invasive Cardiac Surgery Coronary Artery Bypass Grafting(MICS-CABG) and Off-Pump Coronary Artery Bypass(OPCAB). The m…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC
-
Can a simple pill ease stent discomfort? new trial tests two options
Symptom relief Recruiting nowThe goal of this clinical trial is to compare how well Terazosin, Tamsulosin and standard care (no alpha-blocker) reduce urinary symptoms after ureteral stent placement. This trial also learn about the safety of these two study medications. Main objective: • To compare how well…
Phase 3 • Sponsor: Penang Hospital, Malaysia • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
One-Shot fix for AFib? study tests ablation plus watchman in same session
Disease control CompletedThis sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Liver tumor treatment gets a targeted boost: Drug-Loaded beads take aim at metastases
Disease control Recruiting nowTrans arterial chemoembolization (TACE) has emerged as a treatment option for chemotherapy-refractory diseases in Liver metastases. By delivering chemotherapy agents directly to the tumor site, TACE can maximize local drug concentrations and reduce systemic adverse reactions. Bev…
Phase 1/2 • Sponsor: Pardis Noor Medical Imaging and Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Simple blood test could help GPs catch Alzheimer's early
Diagnosis Recruiting nowWhile knowledge about dementia and its causes is increasing rapidly, healthcare systems remain ill-equipped to detect cognitive decline in the early stages of neurodegenerative diseases such as Alzheimer's disease (AD). However, improving the early identification of AD in the pop…
Sponsor: Robert Perneczky • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Pineapple enzyme gel could speed healing of stubborn leg wounds
Disease control Recruiting nowThe main objective of this study is: To assess the efficacy and safety of EscharEx (EX-03 5% formulation) compared to placebo control,in debridement and wound bed preparation of Venous Leg Ulcers (VLU).
Phase 3 • Sponsor: MediWound Ltd • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for hemophilia a: Low-Dose emicizumab may protect joints better
Disease control OngoingRecent studies have shown that pharmacokinetic (PK)-guided extended half-life (EHL) factor VIII can improve joint health in patients with hemophilia A. However, some patients experience suboptimal joint outcomes despite optimized PK-guided therapy. Low-dose emicizumab has emerged…
Phase 2/3 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI takes on hip surgeons in diagnosis showdown
Diagnosis CompletedPrimary Goal: This study aims to evaluate the diagnostic and therapeutic accuracy of GPT-4 (an advanced AI language model) compared to three orthopedic surgeons with varying experience levels in cases of failed or painful total hip arthroplasty. Key Research Questions: Diagnos…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Blood test may spare kidney transplant patients from painful biopsies
Disease control Recruiting nowThe investigator hypothesizes that the combined use of (1) Donor-derived cell-free DNA (dd-cfDNA) in peripheral blood predicting anti-donor immunological activation or quiescence (2) interactive and actionable data analytics delivered at the bedside will promote safe clinical fol…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 13:57 UTC
-
Blood test may spare thousands from unnecessary head scans
Diagnosis OngoingThis study aims to determine whether a blood test can help doctors decide when to use a head CT scan for patients with a mild head injury. Researchers are investigating whether the results from this blood test can aid in making better decisions about patient care and potentially …
Sponsor: Emory University • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New dosing strategy for schizophrenia drug aims to cut side effects
Disease control Recruiting nowThe objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia
Phase 2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:00 UTC
-
Simple cuff training shows promise for Post-Stroke arm recovery
Disease control CompletedBackground; Blood flow restriction training (BFRT) is a physical intervention that promotes many beneficial muscular activities and functions when low load/intensity is used in healthy and clinical populations. Objectives: To determine the effect of BFRT on upper extremity motor…
Sponsor: University of Hail • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a Plant-Based powder cut the need for IV nutrition?
Disease control Recruiting nowA 24-week, randomized, placebo-controlled, double-blind study to evaluate the efficacy, safety and tolerability of crofelemer in patients with Short Bowel Syndrome and Intestinal Failure (SBS-IF) without colon-in-continuity (CIC) requiring parenteral support (PS). Blinded study …
Phase 2 • Sponsor: Napo Therapeutics, S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC